Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3389/FNCEL.2024.1406832 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background Major depression disorder (MDD) and anxiety are common mental disorders that significantly affect the quality of life of those who suffer from them, altering the person's normal functioning. From the biological perspective, the most classical hypothesis explaining their occurrence relies on neurotransmission and hippocampal excitability alterations. However, around 30% of MDD patients do not respond to medication targeting these processes. Over the last decade, the involvement of inflammatory responses in depression and anxiety pathogenesis has been strongly acknowledged, opening the possibility of tackling these disorders from an immunological point of view. In this context, regulatory T cells (Treg cells), which naturally maintain immune homeostasis by suppressing inflammation could be promising candidates for their therapeutic use in mental disorders.Methods To test this hypothesis, C57BL/6 adult male mice were submitted to classical stress protocols to induce depressive and anxiety-like behavior; chronic restriction stress (CRS), and chronic unpredictable stress (CUS). Some of the stressed mice received a single adoptive transfer of Treg cells during stress protocols. Mouse behavior was analyzed through the open field (OFT) and forced swim test (FST). Blood and spleen samples were collected for T cell analysis using cell cytometry, while brains were collected to study changes in microglia by immunohistochemistry.Results Mice submitted to CRS and CUS develop anxiety and depressive-like behavior, and only CRS mice exhibit lower frequencies of circulating Treg cells. Adoptive transfer of Treg cells decreased anxiety-like behavior in the OFT only in CRS model, but not depressive behavior in FST in neither of the two models. In CRS mice, Treg cells administration lowered the number of microglia in the hippocampus, which increased due this stress paradigm, and restored its arborization. However, in CUS mice, Treg cells administration increased microglia number with no significant effect on their arborization.Conclusion Our results for effector CD4+ T cells in the spleen and microglia number and morphology in the hippocampus add new evidence in favor of the participation of inflammatory responses in the development of depressive and anxiety-like behavior and suggest that the modulation of key immune cells such as Treg cells, could have beneficial effects on these disorders.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Cepeda, Yamila | - |
Universidad San Sebastián - Chile
Universidad de Concepción - Chile |
| 2 | ELIZONDO-VEGA, ROBERTO JAVIER | Hombre |
Universidad de Concepción - Chile
|
| 3 | Garrido, Camila | Mujer |
Universidad San Sebastián - Chile
Universidad de Concepción - Chile |
| 4 | Tobar, Catalina | - |
Universidad San Sebastián - Chile
|
| 5 | Araneda, Matias | - |
Universidad San Sebastián - Chile
|
| 6 | Oliveros, Patricia | - |
Universidad San Sebastián - Chile
|
| 7 | Ordenes, Patricio | - |
Universidad San Sebastián - Chile
|
| 8 | Carril, Claudio | - |
Universidad San Sebastián - Chile
|
| 9 | Vidal, Pia M. | Mujer |
Universidad Católica de la Santísima Concepción - Chile
|
| 10 | LUZ-CRAWFORD, PATRICIA ALEJANDRA | Mujer |
Universidad de Los Andes, Chile - Chile
Ctr Intervent Med Precis & Adv Cellular Therapy - Chile Centro de Medicina Intervencional de Precisión y Terapia Celular Avanzada - Chile |
| 11 | de los Angeles Garcia-Robles, Maria | Mujer |
Universidad de Concepción - Chile
|
| 12 | OYARCE-MERICO, KARINA ALEJANDRA | Mujer |
Universidad San Sebastián - Chile
|
| Fuente |
|---|
| Universidad de Concepción |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Fondecyt Regular |
| Universidad Católica de la Santísima Concepción |
| ANID Fondecyt |
| ANID FONDECYT INICIACION |
| ANID-Basal funding for Scientific and Technological Center of Excellence |
| Interventional Medicine for Precision and Advanced Cellular Therapy |
| ImPACT Applications |
| Vicerectoria de Investigacion y Doctorados de la Universidad San Sebastian Fondo |
| ANID-Basal for Scientific and Technological Center of Excellence, IMPACT, Interventional Medicine for Precision and Advanced Cellular Therapy |
| Universidad de Concepcion (Enfoque de Genero VRID) |
| Universidad San Sebastian Fondo |
| Agradecimiento |
|---|
| The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the ANID Fondecyt Iniciacion 11190914, Vicerectoria de Investigacion y Doctorados de la Universidad San Sebastian Fondo USS-FIN-24-APCS-19 and USS-FIN-23-PASI-09, Universidad de Concepcion (Enfoque de Genero VRID 2023000819), Fondecyt Regular N degrees 1221509, Universidad Catolica de la Santisima Concepcion (FIAEC 01/2021), and ANID-Basal funding for Scientific and Technological Center of Excellence, IMPACT, Interventional Medicine for Precision and Advanced Cellular Therapy, #FB210024. |
| The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the ANID Fondecyt Iniciaci\u00F3n 11190914, Vicerector\u00EDa de Investigaci\u00F3n y Doctorados de la Universidad San Sebastian Fondo USS-FIN-24-APCS-19 and USS-FIN-23-PASI-09, Universidad de Concepci\u00F3n (Enfoque de G\u00E9nero VRID 2023000819), Fondecyt Regular N\u00B01221509, Universidad Cat\u00F3lica de la Sant\u00EDsima Concepci\u00F3n (FIAEC 01/2021), and ANID-Basal funding for Scientific and Technological Center of Excellence, IMPACT, Interventional Medicine for Precision and Advanced Cellular Therapy, #FB210024. |